First Manhattan’s iShares Biotechnology ETF IBB Stock Holding History

First Manhattan’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$323K	Hold	1,911	–	–	﹤0.01%	651
2025 Q4	$323K	Hold	1,911	–	–	﹤0.01%	632
2025 Q3	$276K	Sell	1,911 -31	-2%	-$4.23K	﹤0.01%	637
2025 Q2	$246K	Sell	1,942 -4	-0.2%	-$491	﹤0.01%	649
2025 Q1	$249K	Sell	1,946 -498	-20%	-$67.5K	﹤0.01%	616
2024 Q4	$323K	Buy	+2,444	New	+$344K	﹤0.01%	588
2024 Q2	–	Sell	-540	Closed	-$74.1K	–	948
2024 Q1	$74.1K	Hold	540	–	–	﹤0.01%	813
2023 Q4	$73.4K	Hold	540	–	–	﹤0.01%	799
2023 Q3	$66K	Hold	540	–	–	﹤0.01%	820
2023 Q2	$68.6K	Hold	540	–	–	﹤0.01%	830
2023 Q1	$69.7K	Hold	540	–	–	﹤0.01%	865
2022 Q4	$70.9K	Hold	540	–	–	﹤0.01%	881
2022 Q3	$63K	Sell	540 -600	-53%	-$74.5K	﹤0.01%	897
2022 Q2	$134K	Hold	1,140	–	–	﹤0.01%	786
2022 Q1	$148K	Buy	1,140 +540	+90%	+$70.3K	﹤0.01%	813
2021 Q4	$91K	Hold	600	–	–	﹤0.01%	889
2021 Q3	$97K	Hold	600	–	–	﹤0.01%	870
2021 Q2	$98K	Hold	600	–	–	﹤0.01%	865
2021 Q1	$90K	Sell	600 -375	-38%	-$59.6K	﹤0.01%	844
2020 Q4	$147K	Sell	975 -90	-8%	-$12.9K	﹤0.01%	725
2020 Q3	$144K	Buy	1,065 +375	+54%	+$50.9K	﹤0.01%	696
2020 Q2	$94K	Hold	690	–	–	﹤0.01%	780
2020 Q1	$74K	Buy	+690	New	+$79.4K	﹤0.01%	782
2019 Q3	–	Sell	-100	Closed	-$10K	–	1364
2019 Q2	$10K	Buy	+100	New	+$10.6K	﹤0.01%	1182
2017 Q1	–	Sell	-555	Closed	-$49K	–	1417
2016 Q4	$49K	Hold	555	–	–	﹤0.01%	926
2016 Q3	$53K	Hold	555	–	–	﹤0.01%	912
2016 Q2	$47K	Buy	+555	New	+$49.8K	﹤0.01%	961

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return

Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

First Manhattan's IBB Position: Q1 2026 in Review

First Manhattan held its iShares Biotechnology ETF (IBB) position steady in Q1 2026 at 1,911 shares worth $323K. The position accounts for ﹤0.01% of the portfolio, ranked #651.

First Manhattan first reported a position in IBB in Q2 2016 and has held it in 27 quarters since. The position peaked at $323K in Q4 2024. 917 funds tracked by Wall St. Rank hold IBB as of Q1 2026.

First Manhattan held 1,911 shares of iShares Biotechnology ETF worth $323K as of Q1 2026.
First Manhattan left its iShares Biotechnology ETF share count unchanged in Q1 2026.
iShares Biotechnology ETF made up ﹤0.01% of First Manhattan's portfolio in Q1 2026, its #651 holding.
First Manhattan first reported a position in iShares Biotechnology ETF in Q2 2016 and has held it in 27 quarters since.
First Manhattan's iShares Biotechnology ETF position peaked at $323K in Q4 2024.
917 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2026.

Based on First Manhattan's 13F filing for Q1 2026, filed 15 May 2026.